🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This is a research study involving the treatment of patients with hematolog...
Status
Terminated
Location
Thomas Jefferson University
Start Date
2011-04
Trial ID
NCT01350258
Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Status
Recruiting
Location
Saint Louis hospital
Start Date
2025-01-24
Trial ID
NCT06646497
Treatments Being Tested
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
The current national acute lymphoblastic leukaemia (ALL) trial in adults in...
Status
Active Not Recruiting
Location
Heart of England Nhs Foundation Trust
Start Date
2018-11-22
Trial ID
NCT03821610
Treatments Being Tested
The goal of this clinical research study is to learn if it is safe and feas...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-07-13
Trial ID
NCT01471067
This phase I/II trial studies the safety, side effects, and best dose of de...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-09-23
Trial ID
NCT06928662
RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
2000-10
Trial ID
NCT00008151